CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Current Assets History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Current Assets | ₹16,805 Cr | ₹14,711 Cr | ₹13,181 Cr | ₹11,704 Cr | ₹12,425 Cr |
What is the latest Total Current Assets ratio of CIPLA ?
Year | Total Current Assets |
---|---|
Mar2023 | ₹16,805 Cr |
Mar2022 | ₹14,711 Cr |
Mar2021 | ₹13,181 Cr |
Mar2020 | ₹11,704 Cr |
Mar2019 | ₹12,425 Cr |
How is Total Current Assets of CIPLA Trending?
Years | Total Current Assets | % Change | |
---|---|---|---|
Mar2023 | ₹16,805 Cr | 14.24 | |
Mar2022 | ₹14,711 Cr | 11.61 | |
Mar2021 | ₹13,181 Cr | 12.62 | |
Mar2020 | ₹11,704 Cr | -5.80 | |
Mar2019 | ₹12,425 Cr | - |
Compare Total Current Assets of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹115,034.3 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics | |
MANKIND PHARMA | ₹92,708.2 Cr | -2.3% | 0.1% | NA | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 1.1% |
-4.8% |
56.4% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses